235 related articles for article (PubMed ID: 8949885)
1. RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies.
Ruiz A; Aguilar R; Tébar AM; Gaytán F; Sánchez-Criado JE
Biol Reprod; 1996 Dec; 55(6):1284-91. PubMed ID: 8949885
[TBL] [Abstract][Full Text] [Related]
2. Ovary mediates the effects of RU486 given during proestrus on the diestrous secretion of luteinizing hormone in the rat.
Tébar M; Ruíz A; Bellido C; Sánchez-Criado JE
Biol Reprod; 1996 Jun; 54(6):1266-70. PubMed ID: 8724354
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions.
Sánchez-Criado JE; Galiot F; Bellido C; Gonzalez D; Tébar M
Biol Reprod; 1993 Apr; 48(4):916-25. PubMed ID: 8485257
[TBL] [Abstract][Full Text] [Related]
4. Evidence that androgens are involved in atresia and anovulation induced by antiprogesterone RU486 in rats.
Sánchez-Criado JE; Tébar M; Sánchez A; Gaytán F
J Reprod Fertil; 1993 Sep; 99(1):173-9. PubMed ID: 8283435
[TBL] [Abstract][Full Text] [Related]
5. Endocrine and morphological features of cystic ovarian condition in antiprogesterone RU486-treated rats.
Sánchez-Criado JE; Sánchez A; Ruiz A; Gaytán F
Acta Endocrinol (Copenh); 1993 Sep; 129(3):237-45. PubMed ID: 8212989
[TBL] [Abstract][Full Text] [Related]
6. The antiprogestin RU486 dissociates LH and FSH secretion in male rats: evidence for direct action at the pituitary level.
Sánchez-Criado JE; Bellido C; Tébar M; Ruiz A; Gonzalez D
J Endocrinol; 1999 Feb; 160(2):197-203. PubMed ID: 9924188
[TBL] [Abstract][Full Text] [Related]
7. Antiprogestagen RU486 prevents the LH-dependent decrease in the serum concentrations of inhibin in the rat.
Tébar M; Bellido C; Uilenbroek JT; Sánchez-Criado JE
Cell Mol Neurobiol; 1996 Jun; 16(3):283-95. PubMed ID: 8818397
[TBL] [Abstract][Full Text] [Related]
8. Follicular and luteal progesterone play different roles synchronizing pituitary and ovarian events in the 4-day cyclic rat.
Tébar M; Ruiz A; Gaytán F; Sánchez-Criado JE
Biol Reprod; 1995 Nov; 53(5):1183-9. PubMed ID: 8527524
[TBL] [Abstract][Full Text] [Related]
9. Effects of progesterone (P) and antiprogestin RU486 on LH and FSH release by incubated pituitaries from rats treated with the SERM LY11701 8-HCl and/or recombinant human FSH.
Bellido C; Aguilar R; Garrido-Gracia JC; Sánchez-Criado JE
J Endocrinol Invest; 2002 Sep; 25(8):702-8. PubMed ID: 12240902
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of GH, IGF-I, LH and ovarian steroids in cyclic and RU486-treated rats.
Ruiz A; Tébar M; Pérez-Romero A; Rol de Lama MA; Sánchez-Criado JE
J Endocrinol Invest; 1997 Nov; 20(10):611-5. PubMed ID: 9438919
[TBL] [Abstract][Full Text] [Related]
11. Inappropriate ovarian feedback in basal gonadotropin secretion in 4-day cyclic rat treated with mifepristone: role of endogenous estradiol.
Tébar M; Bellido C; Aguilar R; Sánchez-Criado JE
J Endocrinol Invest; 1994 Jun; 17(6):425-30. PubMed ID: 7930387
[TBL] [Abstract][Full Text] [Related]
12. The steroid antagonist RU486 given at pro-oestrus induces hypersecretion of follicle-stimulating hormone from oestrus afternoon to early metoestrus in the rat.
Sánchez-Criado JE; Tébar M; Ruiz A; Padrón L
Eur J Endocrinol; 1997 Sep; 137(3):281-6. PubMed ID: 9330593
[TBL] [Abstract][Full Text] [Related]
13. A possible dual mechanism of the anovulatory action of antiprogesterone RU486 in the rat.
Sánchez-Criado JE; Bellido C; Galiot F; López FJ; Gaytán F
Biol Reprod; 1990; 42(5-6):877-86. PubMed ID: 2116924
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Heikinheimo O; Gordon K; Williams RF; Hodgen GD
Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
[TBL] [Abstract][Full Text] [Related]
15. Relevance of an opioid, noscapine in reducing cystogeneses in rat experimental model of polycystic ovary syndrome.
Priyadarshani A
J Endocrinol Invest; 2009 Nov; 32(10):837-43. PubMed ID: 19609106
[TBL] [Abstract][Full Text] [Related]
16. Recombinant FSH-induced follicle development in immature rats treated with an LHRH antagonist:a direct effect of RU486 on follicular atresia.
Uilenbroek JT; Kramer P; van Leeuwen EC; Karels B; Timmerman MA; de Jong FH; de Leeuw R
J Endocrinol; 1996 Jul; 150(1):85-92. PubMed ID: 8708566
[TBL] [Abstract][Full Text] [Related]
17. The in vitro inhibitory action of antiprogestin RU486 on LH and FSH secretion in the absence of progesterone in rats is estrogen-dependent.
Aguilar R; Bellido C; Gonzalez D; Garrido-Gracia JC; Sánchez-Criado JE
Pituitary; 2000 Nov; 3(3):153-8. PubMed ID: 11383479
[TBL] [Abstract][Full Text] [Related]
18. Effects of progesterone on the secondary surge of follicle-stimulating hormone in the rat.
Tébar M; Uilenbroek JT; Kramer P; van Schaik RH; Wierikx CD; Ruiz A; de Jong FH; Sánchez-Criado JE
Biol Reprod; 1997 Jul; 57(1):77-84. PubMed ID: 9209083
[TBL] [Abstract][Full Text] [Related]
19. Hypersecretion of follicle-stimulating hormone (FSH) on estrous afternoon in rats treated with RU486 in proestrus.
Tébar M; Ruiz A; Sánchez-Criado JE
Cell Mol Neurobiol; 1996 Jun; 16(3):421-6. PubMed ID: 8818408
[TBL] [Abstract][Full Text] [Related]
20. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
